Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000093921

Apexbio Technology LLC Trovafloxacin mesylate 147059-75-4 50mg
SDP

Catalog No. 5000093921
Encompass_Preferred

Trovafloxacin mesylate (CAS 147059-75-4) is a small-molecule inhibitor targeting bacterial DNA topoisomerase IV and DNA gyrase It is designed to interfere with DNA replication and transcription thereby inhibiting bacterial DNA synthesis Trovafloxacin mesylate exerts its biological activity primarily through stabilization of the quinolone-DNA-enzyme complex leading to inhibition of DNA synthesis in bacterial cells In enzymatic assays Trovafloxacin mesylate demonstrates inhibitory activity with IC50 values typically within the nanomolar to low micromolar range depending on bacterial targets and assay conditions Based on these pharmacological properties Trovafloxacin mesylate holds research potential in antibacterial mechanism analysis resistance pathway examination and pharmacological profiling against both Gram-positive and Gram-negative bacteria

Catalog No. 50-000-93921 Supplier Apexbio Technology LLC Supplier No. A864650
May include imposed supplier surcharges.
Add to Cart
Add to Cart

Trovafloxacin mesylate (CAS 147059-75-4) is a small-molecule inhibitor targeting bacterial DNA topoisomerase IV and DNA gyrase It is designed to interfere with DNA replication and transcription thereby inhibiting bacterial DNA synthesis Trovafloxacin mesylate exerts its biological activity primarily through stabilization of the quinolone-DNA-enzyme complex leading to inhibition of DNA synthesis in bacterial cells In enzymatic assays Trovafloxacin mesylate demonstrates inhibitory activity with IC50 values typically within the nanomolar to low micromolar range depending on bacterial targets and assay conditions Based on these pharmacological properties Trovafloxacin mesylate holds research potential in antibacterial mechanism analysis resistance pathway examination and pharmacological profiling against both Gram-positive and Gram-negative bacteria

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.